Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
It places the product directly on the skin or scalp, where the target tissue is located
Curious if peptide therapy is right for you
Covers the 15 August 2025 FDA approval of Tonix Pharmaceuticals' Tonmya (TNX-102 SL sublingual cyclobenzaprine) - the first new Read the full review Neuroscience 1 May 2026 Dihexa for Multiple Sclerosis (MS): Cognitive Impairment, Remyelination & the 2026 UK Review Can Dihexa help MS cognitive impairment or remyelination
Why This Matters for Lyme Although direct Lyme-specific clinical trials are lacking, BPC-157 peptide clinical research Lyme overlaps strongly with symptom pathways: tissue damage, immune dysregulation, and inflammation
Many researchers use both together for comprehensive repair protocols
US$ 24.50
US$ 21.47
US$ 25.08
US$ 20.18
US$ 27.36
US$ 24.28
US$ 23.38
